FIELD: medicine.
SUBSTANCE: level of FGF-23 is determined in the blood plasma of patients with chronic kidney disease by ELISA. An increase in the level of fibroplastic growth factor-23 indicates a high risk of damage to the cardiovascular system.
EFFECT: increased accuracy of cardiovascular disasters risk diagnosis.
2 dwg
Authors
Dates
2017-10-31—Published
2016-07-05—Filed